If a caregiver is in a situation where they already feel somewhat hesitant about interacting with the medical community, that can create additional challenges. If the best path forward for that patient is genetic testing of some kind, for example, and there's scepticism among patients from that community about that sort of testing and what it'll be used for, it could delay or even prevent a diagnosis from happening. " #EDIRead the interview with GG CEO Craig Martin at Rare Revolution Magazine here.
28 Argonaut, Suite 150Aliso Viejo, CA 92656
Phone: (+1) 949-248-RARE (7273)
Join the GAA - Global Advocacy AllianceJoin the Corporate Alliance